Navigation Links
GeneLink Reports 2010 Results
Date:4/4/2011

ORLANDO, Fla., April 4, 2011 /PRNewswire/ -- GeneLink, Inc. (OTCBB: GNLK, "the Company," or "GeneLink"), a leading consumer genomics biotech company, today reported financial results for the fiscal year ended December 31, 2010.

Financial Highlights:

  • Gross margin increased from $4,906,710 in 2009 to $4,997,367 in 2010;
  • Annual net sales decreased 8.4%, $7,839,972 for 2010 as compared to $8,561,455 in 2009;
  • Operating losses in 2010 decreased to $2,169,898, a decrease of $292,329 from operating losses of 2009.  Excluding non-cash charges relating to the granting of stock, options and warrants, operating losses decreased $589,078 for 2010 as compared to 2009.

Dr. Bernard Kasten, GeneLink's Chairman and CEO stated, "The steps we took to improve our profit margins beginning in late 2009 and throughout 2010 have begun to show results.  Despite a decrease in revenue, gross margin improved $90,657 from $4,906,710 in 2009 to $4,997,367 in 2010. As a percent-of-revenue, the gross margins increased from 57% in 2009 to 64% in 2010.  This was largely due to improved pricing instituted late in 2009, as well as management's efforts to better control costs related to production.  These enhanced fundamentals bode well for the future financial success of GeneLink, as the Company expects to return to growth in the second half of 2011 through channel partner expansion as well as through growth in GeneWize."

Dr. Kasten added: "2010 was an important year from GeneLink.  We have put in place a large portion of the infrastructure necessary to expand our revenue base. The year-end agreement with Robert Trussell, founder of Tempur-pedic, Inc., to market GeneLink's proprietary products through his experienced direct response team is expected to commence producing revenue in the second half of 2011. GeneLink is now focused on our strengths in support of our channel partners:  cutting edge genetic research, reliable genetic testing, innovative and scientifically advanced product development, personalized manufacturing, protection of our intellectual property, and responsiveness to the developing regulatory environment.  I look forward to a very exciting 2011 for GeneLink and its shareholders."

About GeneLink Biosciences, Inc.:

GeneLink is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA test assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer's wellness needs. For more information visit www.genelinkbio.com

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE GeneLink, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
2. GeneLink Reports First Quarter Gains
3. GeneLink Announces HelixLife Private Label Distribution Agreement
4. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
5. GeneLink Reports Third Quarter Results
6. GeneLink Announces New Licensing Partner
7. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
8. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
9. Par Pharmaceutical Reports Second Quarter 2008 Results
10. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
11. Pharmos Corporation Reports 2008 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Media Cybernetics, global ... Media Cybernetics corporate branding reflects a results-driven revitalization for a company with a ... re-branding components include a crisp, refreshed logo and a new web presence. , ...
(Date:5/23/2016)... WARSAW, Ind. , May 23, 2016 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the second quarter of 2016. ... on or about July 29, 2016 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... management solutions and services based in Aurora, Ohio, has broken ground on a ... in the Research Triangle Park area, this new location solidifies a commitment to ...
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary Medicine Company, VetStem ... have treated over 100 of their own patients with the VetStem Cell Therapy. Each ... of care for their patients. , The veterinarians are Dr Ross Rich former ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):